Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOMA
2276
Loma Negra
LOMA
$888M
| $1.65M | ﹤0.01% |
+387,762
| New | +$1.65M |
|
2277
FB Financial Corp
FBK
$2.86B
| $1.65M | ﹤0.01% |
66,600
-42,700
| -39% | -$1.06M |
|
2278
iShares Russell 1000 ETF
IWB
$44.5B
| $1.65M | ﹤0.01% |
9,600
-1,100
| -10% | -$189K |
|
2279
Jakks Pacific
JAKK
$199M
| $1.65M | ﹤0.01% |
200,931
-16,774
| -8% | -$138K |
|
2280
KKR & Co
KKR
$128B
| $1.65M | ﹤0.01% |
+53,350
| New | +$1.65M |
|
|
SCX
2281
DELISTED
The L.S. Starrett Company
SCX
| $1.65M | ﹤0.01% |
485,915
+14,593
| +3% | +$49.5K |
|
2282
Boise Cascade
BCC
$3.2B
| $1.64M | ﹤0.01% |
43,700
-83,600
| -66% | -$3.15M |
|
2283
International Bancshares
IBOC
$4.39B
| $1.64M | ﹤0.01% |
51,337
-187,900
| -79% | -$6.02M |
|
2284
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.76B
| $1.64M | ﹤0.01% |
152,900
+110,704
| +262% | +$1.19M |
|
2285
First Trust Dow Jones Internet Index Fund ETF
FDN
$7.82B
| $1.64M | ﹤0.01% |
9,600
+6,000
| +167% | +$1.02M |
|
|
STZ.B
2286
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.64M | ﹤0.01% |
9,700
| – | – |
|
2287
Dorian LPG
LPG
$1.35B
| $1.64M | ﹤0.01% |
211,222
-251,298
| -54% | -$1.95M |
|
|
RNTX
2288
Rein Therapeutics, Inc. Common Stock
RNTX
$28M
| $1.63M | ﹤0.01% |
69,194
+45,335
| +190% | +$1.07M |
|
2289
Green Brick Partners
GRBK
$3.21B
| $1.63M | ﹤0.01% |
137,735
+60,000
| +77% | +$711K |
|
2290
KT
KT
$9.52B
| $1.63M | ﹤0.01% |
167,500
-93,700
| -36% | -$912K |
|
|
ATYR
2291
aTyr Pharma
ATYR
$591M
| $1.62M | ﹤0.01% |
365,830
+156,830
| +75% | +$696K |
|
|
BBQ
2292
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.62M | ﹤0.01% |
492,741
+4,500
| +0.9% | +$14.8K |
|
2293
Fortress Biotech
FBIO
$116M
| $1.62M | ﹤0.01% |
40,267
+6,967
| +21% | +$280K |
|
2294
Middlefield Banc Corp
MBCN
$245M
| $1.62M | ﹤0.01% |
77,940
-17,872
| -19% | -$371K |
|
|
WRI
2295
DELISTED
Weingarten Realty Investors
WRI
| $1.62M | ﹤0.01% |
85,400
-910,919
| -91% | -$17.2M |
|
2296
Castle Biosciences
CSTL
$621M
| $1.61M | ﹤0.01% |
42,836
+9,636
| +29% | +$363K |
|
2297
First United
FUNC
$239M
| $1.61M | ﹤0.01% |
120,991
+7,490
| +7% | +$99.9K |
|
2298
ProShares UltraPro Short QQQ
SQQQ
$2.2B
| $1.61M | ﹤0.01% |
+1,708
| New | +$1.61M |
|
2299
Century Casinos
CNTY
$76.3M
| $1.61M | ﹤0.01% |
388,049
-483,117
| -55% | -$2M |
|
2300
Corbus Pharmaceuticals
CRBP
$116M
| $1.61M | ﹤0.01% |
+6,387
| New | +$1.61M |
|